Pharma bonanza for cardiologists

Cardiologists can make serious money from their relationships with drug companies, according to US data published as a requirement of new transparency legislation.

Analysis of the Open Payments Database by the publication CardioBrief shows pharmaceutical companies paid US doctors over US$300 million between August 2013 and December 2014 in consulting, speaking fees and other expenses related to cardiovascular drugs. The amount does not include the much